(redirected from adenocarcinoma of the prostate)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to adenocarcinoma of the prostate: Gleason scale
?Note: This page may contain content that is offensive or inappropriate for some readers.
Category filter:
ACAPApplication Configuration Access Protocol
ACAPArmy Career and Alumni Program
ACAPApplication Control Access Protocol
ACAPAtlantic Coastal Action Program
ACAPAssociation of Consumer Affairs Professionals (Japan)
ACAPAdvisory Committee on the Auditing Profession (US Department of the Treasury)
ACAPAdvanced Common Application Platform
ACAPAgreement on the Conservation of Albatrosses and Petrels (international treaty)
ACAPAlternative Cover Assesment Program
ACAPAccord sur la Conservation des Albatros et des Pétrels (French: Agreement on the Conservation of Albatrosses and Petrels)
ACAPAssociação do Comércio Automóvel de Portugal
ACAPAviation Consumer Action Project (Washington, DC)
ACAPAfrican Census Analysis Project
ACAPAs Close As Possible
ACAPAnalyst Capability
ACAPAustralian College of Ambulance Professionals (Australia)
ACAPAlliance of Claims Assistance Professionals
ACAPAnimal Care Application (ethical research form; Institutional Animal Care and Use Committee)
ACAPAged Care Assessment Program
ACAPAirport Capital Assistance Program (Canada)
ACAPAdvanced Capabilities
ACAPAmerican Council on Alcohol Problems
ACAPAdvanced Composite Airframe Program
ACAPAlien Criminal Apprehension Program (Immigrations and Customs Enforcement)
ACAPAfrican Caribbean Achievement Project
ACAPAlberta Coalition Against Poverty (Canada)
ACAPAIDS/HIV Care Access Project
ACAPAutomatic Circuit Analysis Program
ACAPArmy Cost Analysis Paper
ACAPAirplane Characteristics for Airport Planning (aviation)
ACAPAlliance for Constructive Air Policy
ACAPAzimuthally Collapsed Antenna Pattern
ACAPAlarm Control and Annunciator Panel
ACAPAdvisory Council for Administrative Professionals
ACAPAir Command Acoustic Processing
ACAPAdaptive Channel-Access Protocol
ACAPArmy Cost Analysis Position
ACAPAdenocarcinoma of the Prostate (prostate cancer)
ACAPAssessment Correlation and Analysis Process
ACAPAvionics for Composite Aircraft Plan
ACAPAny Channel Any Protocol
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Mucinous adenocarcinoma of the prostate is a rare subtype of prostate cancer characterized by large pools of extracellular mucins, which by definition comprise at least 25% of the tumor volume.
Our findings suggest that the diagnosis of ductal and acinar adenocarcinoma of the prostate can be based on pathological and immunohistochemical examinations.
Metastatic adenocarcinoma of the prostate as a cause of subdural hematoma.
Final pathology was consistent with metastatic adenocarcinoma of the prostate. Postoperatively, magnetic resonance images indicated homogenous enhancement of the subdural mass (Figure 2).
Immunohistochemical localization of prostate-specific antigen in stage A2 adenocarcinoma of the prostate: Prognostic implications.
This specimen was reported as an adenocarcinoma of the prostate. The patient's prostate-specific antigen level was 91 ng/ml (range of normal: 0.0 to 4.0).
The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate. J Urol 1989; 141: 1378-80.
Unsuspected adenocarcinoma of the prostate in patients undergooing cystoprostatectomy for other causes: incidence, histology and morphometric observations.
Baxter focused on patients with invasive, nonmetastatic, adenocarcinoma of the prostate who entered the registry during 1973-1994, a total of more than 85,000 men.
Autopsy studies have shown that a third of adults have cancer cells in their thyroid; up to 40 percent of women in their 40s have ductal carcinoma in situ in their breasts; and half of men in their 60s have adenocarcinoma of the prostate. Yet each of the subjects died of other diseases.
Prostate-specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate [Review].
Adenocarcinoma of the prostate. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, eds.